Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Subscribe to see Akums Drugs and Pharmaceuticals Limited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Akums Drugs and Pharmaceuticals Limited is a pharmaceuticals company headquartered in Delhi, India. It is publicly listed (AKUMS) with a market capitalisation of $1.2B. Xcout tracks 9 named people at Akums Drugs and Pharmaceuticals Limited, including Sanjay Sinha (Whole Time Director and President - Operations).
3 more named people on record for Akums Drugs and Pharmaceuticals Limited, with roles, board committees and tenure — see the full roster →
A few of Akums Drugs and Pharmaceuticals Limited's closest competitors — see the full list of competitors and alternatives →
Kilitch Drugs (India) Limited is a global pharmaceutical company and contract manufacturer that produces a wide range of pharmaceutical formulations, including parenteral products, liquid injectables, antibiotics, nutraceuticals, and over-the-counter medications. The company serves healthcare professionals and patients internationally by supplying certified pharmaceutical products across various dosage forms.
Divi's Laboratories manufactures generic Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients, while also providing custom synthesis services for pharmaceutical companies. The company serves global pharmaceutical, nutritional, food, and beverage industries by supplying small molecules, peptides, carotenoids, and vitamins.
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical ingredients (APIs) and chemical intermediates, which serve as crucial building blocks for final drug products. Additionally, PSAI provides contract research services and produces custom-specified APIs and steroids for clients. The Proprietary Products segment is dedicated to the research and advancement of unique pharmaceutical formulations. The Others segment is actively involved in developing treatments, primarily for oncology (cancer) and inflammatory conditions. Dr. Reddy's addresses a broad spectrum of therapeutic areas, including gastrointestinal issues, cardiovascular health, diabetes, dermatological concerns, cancer, respiratory diseases, oral health, urological disorders, and nephrological conditions. The company has also established a partnership with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists designed for immuno-oncology and precision oncology targets. Founded in 1984, Dr. Reddy's Laboratories Limited maintains its principal office in Hyderabad, India.
Supriya Lifescience Limited is a generic pharmaceutical company that develops and manufactures Active Pharmaceutical Ingredients (APIs), finished dosage formulations (FDFs), and therapeutic products. The company serves a global customer base across more than 85 countries, providing pharmaceutical ingredients and contract development and manufacturing (CDMO) services.
Krebs Biochemicals and Industries Limited is an Indian pharmaceutical manufacturer focused on producing active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fermentation-based products. It supplies pharmaceutical companies in India and international markets, including through contract manufacturing and custom-production services.
Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.